Health & Wellness
In the NIAMS-sponsored, randomized, double-blind clinical trial of 150 women (90 percent) and men with the condition, Lesley M. Arnold, M.D., director of the Women's Health Research Program at the University of Cincinnati College of Medicine, and her colleagues found that those taking gabapentin at dosages of 1,200 to 2,400 mg daily for 12 weeks displayed significantly less pain than those taking placebo. Patients taking gabapentin also reported significantly better sleep and less fatigue. For the majority of participants, the drug was well tolerated. The most common side effects included dizziness and sedation, which were mild to moderate in severity in most cases.
NIAMS Director Stephen I. Katz. M.D., Ph.D., remarked that "While gabapentin does not have Food and Drug Administration approval for fibromyalgia, I believe this study offers additional insight to physicians considering the drug for their fibromyalgia patients. Fibromyalgia is a debilitating condition for which current treatments are only modestly effective, so a study such as this is potentially good news for people with this common, painful condition."
Results of a midstage clinical trial are expected to be presented this week that will show that patients treated with the drug, Dimebon, did better than those receiving a placebo on all five measures of cognition and behavior.
They could lead to a fertility revolution, allowing women to wait longer to have a child.
The dramatic news came from fertility expert Professor Robert Winston. He told a conference that researchers had found a protein which they believe could be developed into a pill or an injection to extend the life of women's eggs.
Health Minister Datuk Seri Dr Chua Soi Lek said the 16-year-old youth was now being treated at the Kuala Terengganu Hospital after he had fever and coughing.
The spread of dengue, which is transmitted by the Aedes aegypti mosquito and is endemic in much of the region, has also accelerated in recent years due to increasing urbanization and travel or migration within the region, experts say.
Traumatic brain injury has become a high-profile condition, thrust into the national spotlight now that thousands of troops who have left the war zone continue to struggle with the consequences of combat. Better known as TBI, the ailment is a physical wound caused by the head-rattling shockwaves associated with bomb explosions that tear brain cells apart.
But TBI shares many of the same symptoms with a common battlefield psychological condition known as post-traumatic stress disorder. Both are often marked by depression, mood swings, irritability, problems concentrating, and memory dysfunction. The similarities can cause healthcare professionals to overlook mild traumatic brain injuries, especially when a patient lacks visible wounds, according to doctors and veterans advocates familiar with the issue.
Andreas Zimmer at the University of Bonn in Germany, and colleagues created a group of mice that lack the receptor for endocannabinoids - forms of THC produced naturally in the body. The team noticed that the mice soon developed a severe skin allergy to the nickel in the metal tags the researchers had fastened to their ears.
Zimmer set up a series of experiments to test the anti-allergy effect of natural and synthetic THC compounds.
One in three people in Britain can expect to suffer from some form of allergy during their lifetime - including 2 million people in the UK thought to have some allergy to food - but there has been barely any increase in NHS services to cope with this. Experts will warn this week that demand for care is outstripping the NHS's ability to cope, and many patients go to private clinics or dietitians that may offer unconventional diets.
Fourteen people in six Western states have fallen ill after eating the beef but all have recovered, the department said.